Filing Details
- Accession Number:
- 0000914062-13-000239
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-10-09 17:12:08
- Reporting Period:
- 2013-10-07
- Filing Date:
- 2013-10-09
- Accepted Time:
- 2013-10-09 17:12:08
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1133416 | Galectin Therapeutics Inc | GALT | Pharmaceutical Preparations (2834) | 043562325 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1456614 | D Rod Martin | C/O Galectin Therapeutics, Inc. 4960 Peachtree Industrial Blvd, Ste 240 Newton MA 02459 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2013-10-07 | 100,000 | $11.79 | 8,969,422 | No | 4 | S | Indirect | By 10X Fund, L.P. |
Common Stock | Disposition | 2013-10-08 | 12,000 | $12.36 | 8,957,422 | No | 4 | S | Indirect | By 10X Fund, L.P. |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | By 10X Fund, L.P. |
No | 4 | S | Indirect | By 10X Fund, L.P. |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 91,488 | Direct |
Footnotes
- Reflects weighted average price. Range of prices were between $11.5335 and $12.136. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- Reflects weighted average price. Range of prices were between $12.00 and $12.51. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- Reporting Person is a managing member of 10X Capital Management, LLC, a Florida limited liability company acting as the general partner of 10X Fund, L.P., a Delaware limited partnership, and as such, may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. Mr. Martin disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.